Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
Despite recent advances in the treatment of multiple myeloma (MM), it remains an incurable disease potentially due to the presence of resistant myeloma cancer stem cells (MM-CSC). Although the presence of clonogenic cells in MM was described three decades ago, the phenotype of MM-CSC is still contro...
Guardado en:
Autores principales: | Teresa Paíno, María E Sarasquete, Bruno Paiva, Patryk Krzeminski, Laura San-Segundo, Luis A Corchete, Alba Redondo, Mercedes Garayoa, Ramón García-Sanz, Norma C Gutiérrez, Enrique M Ocio, Jesús F San-Miguel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ed73b7d077a49e0b8fcf3a00b27cc9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study
por: Mousa A Al-Abbadi, et al.
Publicado: (2016) -
Acta No. 138
por: Banco Central de Chile
Publicado: (2019) -
MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Margaret Yeh, et al.
Publicado: (2021) -
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice
por: Yang C, et al.
Publicado: (2013) -
EVALUATION OF ENDOMETRIAL BIOPSIES FOR CHRONIC ENDOMETRITIS BY USING SYNDECAN-1 (CD138) IN ABNORMAL UTERINE BLEEDING
por: Aaminah Hanif, et al.
Publicado: (2019)